Thanks kpax. I see what you've done and the time, and more time, it would have taken.Been pondering monepantel and it seems to me that with its attributes, monepantel is fairly described as an immuno-oncology drug or at minimum, as a complementary I-O drug.
I-O is the future of cancer treatment and to place it there, I think every announcement should be prefaced "Immuno-oncology drug, moneptantel ...What do you think?
Covi-Pantel . NZ Trader Release, page-1128
-
- There are more pages in this discussion • 313 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 537419 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 140000 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |